Healthcare Triangle Secures $1.63 Million Through Warrant Inducement Program

Healthcare Triangle, Inc. has secured approximately $1.63 million in gross proceeds through a warrant inducement agreement with existing accredited and institutional investors. The digital transformation solutions provider for healthcare and life sciences announced the completion of warrant exercise agreements covering 812,775 shares of common stock.

The transaction involves existing warrant holders exercising their warrants at a reduced price of $2.00 per share, down from the original $20.92 exercise price. In exchange for the immediate exercise generating $1.63 million in cash proceeds, investors will receive new warrants to purchase an equal number of shares at $3.00 per share. These new warrants become exercisable once stockholder approval is obtained and will remain valid for five years from that approval date.

This capital infusion comes at a critical time for Healthcare Triangle as the company continues to expand its digital transformation services in the highly regulated healthcare and life sciences sectors. The funding will support the company's ongoing initiatives in cloud computing, data management, and security compliance solutions that are essential for healthcare organizations navigating increasing digital demands.

WallachBeth Capital served as the sole placement agent for the warrant inducement transaction, facilitating the agreement between Healthcare Triangle and its investors. The transaction closed on October 2, 2025, following satisfaction of customary closing conditions.

The importance of this funding extends beyond immediate financial benefits. Healthcare Triangle's HITRUST Certification for Cloud and Data Platform demonstrates the company's commitment to maintaining the highest standards for data protection and information security. This certification, combined with fresh capital, positions the company to better serve healthcare organizations facing mounting pressure to improve data utilization while maintaining strict compliance with regulatory requirements.

For the healthcare industry, this development signals continued investment in digital infrastructure at a time when hospitals, health systems, payers, and pharmaceutical companies are accelerating their digital transformation efforts. The capital raised through this warrant inducement will enable Healthcare Triangle to enhance its CloudEz™ and DataEz™ platforms, which are critical tools for healthcare organizations seeking to optimize clinical and business performance through improved technology adoption.

The warrant restructuring also reflects investor confidence in Healthcare Triangle's strategic direction and market position. By converting existing warrants into new instruments with higher exercise prices, both the company and its investors demonstrate shared expectations for future growth and valuation improvement. This type of financing arrangement typically indicates mutual belief in the company's ability to execute its business plan and create long-term shareholder value.

As healthcare organizations worldwide face increasing cybersecurity threats and regulatory complexity, companies like Healthcare Triangle play a vital role in ensuring that digital transformation occurs securely and efficiently. The $1.63 million capital injection will support the company's mission to reinforce healthcare progress through breakthrough technology and industry expertise, ultimately benefiting healthcare providers and patients through improved technology infrastructure and data management capabilities.